Holen Sie sich die Stockscreener-App
127.88
1.95%
2.44
Vorhandelsmarkt:
127.38
-0.50
-0.39%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina, Inc. $ILMN Shares Sold by KLP Kapitalforvaltning AS - MarketBeat
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility - Illumina
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Universal Beteiligungs und Servicegesellschaft mbH Sells 15,739 Shares of Illumina, Inc. $ILMN - MarketBeat
Human Microbiome Sequencing Technology Market Competitive - openPR.com
Omics-Based Clinical Trials Research Report 2026: $47.78 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
AML Complexity Uncovered: - Illumina
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
DNA Extraction, Isolation and Purification Market: Key Players - openPR.com
OVERSEA CHINESE BANKING Corp Ltd Decreases Stock Position in Illumina, Inc. $ILMN - MarketBeat
Gene Expression Analysis Market Set for Robust Growth to USD - openPR.com
Illumina Inc. (ILMN) – Pediatric Genomics Collaboration Bolsters Long-Term Growth Narrative Amid Mixed Historical ReturnsFast Rising Picks - UBND thành phố Hải Phòng
Belpointe Asset Management LLC Purchases Shares of 9,592 Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. (ILMN) Launches DRAGEN v4.5 Bioinformatics Suite, Expanding Addressable Market in Genomic Research and Clinical OncologyPost Announcement - Xã Thanh Hà
South America Next Generation Sequencing eDNA Biomonitoring - openPR.com
Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com
Pharmacogenomics Market Leading Companies | F. Hoffmann-la - openPR.com
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Tsinghua University brings hands-on multiomics training to young scientists - Illumina
UPS, Netflix, BlackRock And A Health Care Stock On CNBC's 'Final Trades'BlackRock (NYSE:BLK), Illumina - Benzinga
Fortis Capital Advisors LLC Invests $1.26 Million in Illumina, Inc. $ILMN - MarketBeat
Asset Management One Co. Ltd. Grows Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
KBC Group NV Has $5.90 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. Common Stock Ex-distribution When-Issued (ILMNV) - Minichart
Behavioral Patterns of ILMN and Institutional Flows - Stock Traders Daily
Illumina, Inc. $ILMN Shares Acquired by Cwm LLC - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN), Labcorp (LH) expand precision oncology NGS collaboration - MSN
ILMN Stock Price, Quote & Chart | ILLUMINA INC (NASDAQ:ILMN) - ChartMill
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows - PR Newswire
Robeco Institutional Asset Management B.V. Trims Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Illumina Inc. stock (US4523271090): Why does its genomics dominance matter more now for U.S. investo - AD HOC NEWS
Illumina’s Pediatric Genomics Push Tests Long Term Growth Narrative - Yahoo Finance
Illumina partners with D3b on pediatric genomic data initiative By Investing.com - Investing.com Canada
How Investors Are Reacting To Illumina (ILMN) Board Turnover And Expanded Labcorp Precision Oncology Partnership - simplywall.st
Illumina partners with D3b on pediatric genomic data initiative - Investing.com
Illumina Partners with D3b to Advance Pediatric Cancer Research - Intellectia AI
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease - PR Newswire
Third View Private Wealth LLC Buys Shares of Illumina, Inc. - National Today
Third View Private Wealth LLC Buys Shares of 16,207 Illumina, Inc. $ILMN - MarketBeat
Massachusetts Financial Services Co. MA Invests $73.53 Million in Illumina, Inc. $ILMN - MarketBeat
Hardman Johnston Trims Illumina Stake - National Today
Illumina, Inc. $ILMN Shares Sold by Hardman Johnston Global Advisors LLC - MarketBeat
Illumina, Inc. $ILMN Holdings Decreased by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Baillie Gifford & Co. Reduces Position in Illumina, Inc. $ILMN - MarketBeat
ILMN Q4 2025 Earnings: Illumina Inc. beats EPS views, no revenue reportedCommunity Pattern Alerts - Xã Thanh Hà
Bioinformatics Market 2026- 2033 Overview: Share, Size, Value, - openPR.com
0.42%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):